Shaking in cancer patients stems from a surprisingly wide range of causes, from infections and metabolic shifts to the side effects of treatment itself and, less commonly, the direct or indirect actions of the tumor on the nervous system. The type of shaking matters: violent, whole-body rigors during a fever episode have a completely different origin than a persistent hand tremor or sudden jerking movements. Because cancer patients are typically dealing with multiple medications, a suppressed immune system, and shifting body chemistry all at once, pinpointing the cause often requires untangling several overlapping factors.
Infection and the Classic Rigor
One of the most common and most urgent causes of shaking in cancer patients is infection. Many cancer treatments, particularly chemotherapy, suppress white blood cell counts and leave patients neutropenic, meaning their immune defenses are dangerously low. When an infection takes hold in this setting, the body’s inflammatory response can trigger intense shaking chills known as rigors. These are not ordinary shivers from being cold. Rigors involve rapid, rhythmic muscle contractions that can be severe enough to make the bed shake, and they often signal that bacteria or other pathogens have entered the bloodstream.
What makes this especially tricky is that neutropenic patients do not always develop a fever alongside their infection. A study of afebrile neutropenic cancer patients with severe infections found that these patients presented with hypotension, severe fatigue, shaking chills, or altered mental state, and all eventually deteriorated into severe sepsis or septic shock.1PubMed Central. Outcome of severe infections in afebrile neutropenic cancer patients The absence of fever can lull caregivers into thinking the situation is less serious than it is. If a cancer patient on active treatment suddenly develops shaking chills, the medical team typically treats it as a potential emergency, drawing blood cultures and starting antibiotics quickly rather than waiting for a temperature spike.
Treatment-Related Rigors From Immunotherapy and Biological Agents
Some of the most intense shaking cancer patients experience comes not from the disease but from the drugs used to fight it. High-dose interleukin-2 (IL-2), an immunotherapy used in melanoma and kidney cancer, is notorious for causing rigors. The drug triggers a massive release of cytokines, the immune system’s signaling molecules, which produces flu-like symptoms including fevers, chills, muscle aches, and joint pain. Chills typically develop within one to two hours of the first or second dose and are treated with repeated doses of opioid medication and warm blankets.2BMC Cancer. Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2
Monoclonal antibody therapies, another pillar of modern cancer treatment, can cause infusion reactions that include rigors. These reactions happen because the immune system responds to the foreign protein being infused, and the shaking can be dramatic enough to require intervention. A comparison of opioid treatments for these rigors found that a single dose of intravenous opioid was sufficient to stop the shaking in most patients, with only about one in five needing a second dose regardless of whether meperidine or morphine was used.3PubMed Central. Meperidine compared to morphine for rigors associated with monoclonal antibody-related infusion reactions Sedation rates were low in both groups, around 10%. For patients and families witnessing these episodes for the first time, the violence of the shaking can be alarming, but treatment teams generally manage them as an expected and controllable side effect.
Antiemetics and Other Medications That Cause Movement Disorders
Cancer patients take a lot of medications, and some of them can cause shaking as an unintended side effect. One underappreciated culprit is the class of drugs used to control nausea and vomiting during chemotherapy. Metoclopramide and olanzapine, commonly prescribed as antiemetics in oncology, both act on dopamine receptors in the brain. When used together or over extended periods, they can cause extrapyramidal symptoms: involuntary movements, tremors, muscle stiffness, and restlessness that resemble Parkinson’s disease.
A case report documented a patient who developed prolonged extrapyramidal symptoms after seven months of intermittent low-dose olanzapine combined with metoclopramide and palonosetron for chemotherapy-induced nausea.4PubMed Central. Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report The key problem was that multiple drugs with overlapping dopamine-blocking activity were stacking on top of each other, creating a cumulative effect even though each individual dose seemed small. Patients and oncologists alike sometimes attribute new tremors or stiffness to cancer progression or general debility when the real cause is sitting in the medication list. Recognizing drug-induced movement disorders matters because the fix is often straightforward: adjust or stop the offending medication.
Metabolic Disturbances
Cancer and its treatments can throw body chemistry out of balance in ways that directly cause shaking, muscle spasms, or tremors. Calcium is one of the most important minerals for normal muscle and nerve function, and cancer patients are vulnerable to abnormal calcium levels from multiple directions. Bone metastases can release calcium into the blood, while bone-protecting drugs like bisphosphonates (zoledronic acid, for example) can drive calcium dangerously low.
A case report described a 74-year-old woman with metastatic breast cancer and extensive bone metastases who developed severe hypocalcemia after receiving zoledronic acid. Her calcium and vitamin D supplements had been discontinued when she was admitted to a palliative care unit, and she subsequently developed persistent nausea, vomiting, and bronchospasm. Her corrected calcium dropped to a critically low level, and symptoms resolved only after intravenous calcium was administered.5PubMed Central. Case report of severe hypocalcemia with atypical symptoms after zoledronic acid in palliative care: a deprescribing pitfall What made this case instructive was that the classic neuromuscular signs of hypocalcemia, such as twitching and spasms, were initially absent. Instead, the symptoms were atypical enough to be blamed on other causes. Magnesium, potassium, and sodium imbalances can produce their own forms of tremor and muscle irritability, and cancer patients frequently deal with several of these at once due to poor nutrition, vomiting, kidney problems, or medications.
When the Tumor Itself Affects the Brain
Tumors that grow in or press on certain parts of the brain can directly cause tremors, slow movements, and rigidity. The basal ganglia, a cluster of structures deep in the brain, coordinate smooth voluntary movement. When a tumor compresses or invades these areas, the result can look almost identical to Parkinson’s disease. A 59-year-old woman presented with several months of increasing tremor in her left hand. Neurological examination revealed a resting tremor, slowness of movement, reduced speech rate, and cogwheel rigidity. Imaging showed a large meningioma in the right frontal area pressing on the frontal lobe and the lenticular nucleus, one of the basal ganglia structures.6PubMed Central. Brain Tumor Presenting with Parkinsonism
This kind of presentation is uncommon, but it illustrates an important point: not all shaking in cancer patients is caused by treatment or infection. A new tremor, especially one that is one-sided and progressive, warrants imaging to rule out a brain lesion. Both primary brain tumors and metastases from cancers elsewhere in the body (lung, breast, and melanoma metastasize to the brain frequently) can produce these symptoms depending on their location.
Paraneoplastic Syndromes and the Immune System’s Friendly Fire
Some of the most puzzling cases of shaking in cancer patients come from paraneoplastic syndromes, conditions where the immune system, in trying to fight the cancer, accidentally attacks healthy nervous tissue. The tumor produces proteins that resemble normal brain or nerve proteins, and antibodies directed against the tumor end up damaging the nervous system as collateral damage. These syndromes can produce a wide range of movement disorders, from subtle tremors to violent jerking movements.
Paraneoplastic movement disorders are a mixed group that includes both hyperkinetic conditions (too much movement, like chorea, myoclonus, and tremor) and hypokinetic conditions (too little movement, like rigidity and slowness). They typically appear suddenly or progress quickly and involve multiple areas of the nervous system, which helps distinguish them from more common neurological conditions that tend to progress slowly and stay localized.7PubMed. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment Different cancers are associated with different antibodies and different movement patterns. Anti-Yo antibodies, often linked to ovarian and breast cancers, can cause cerebellar ataxia and tremor. Anti-NMDA receptor antibodies can cause involuntary movements, abnormal posturing, and writhing motions. The spectrum also includes stiff-person syndrome, where muscles become painfully rigid, and opsoclonus-myoclonus-ataxia, a striking syndrome of chaotic eye movements, sudden muscle jerks, and unsteady gait.8PubMed Central. Movement disorders in paraneoplastic and autoimmune disease
A case report of a 78-year-old man with non-small cell lung cancer documented how he initially presented with mild tremulousness that rapidly progressed to severe, widespread myoclonus with prominent palatal involvement, eventually requiring intubation.9PubMed Central. A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer The speed of deterioration is characteristic of paraneoplastic syndromes and is part of what makes them so dangerous. Sometimes the movement disorder appears before the cancer itself has been diagnosed, effectively serving as the first clue that a malignancy exists. Treatment usually involves addressing the underlying cancer and suppressing the immune response with immunotherapy, though outcomes are variable and depend heavily on the specific antibody involved and how early treatment begins.
Opioid Withdrawal During Pain Management Changes
Cancer patients who have been on opioid pain medications for an extended period face a less obvious source of shaking: withdrawal. As cancer treatment succeeds or as palliative goals shift, clinicians may begin tapering opioid doses. The body, now physically dependent on these medications, responds to the reduction with a stress response driven largely by cortisol and catecholamines. Symptoms include sweating, restlessness, muscle twitching, tremors, nausea, and a generally agitated state that can look alarming.10PubMed Central. Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain
What makes opioid withdrawal particularly confusing in oncology is that its symptoms can mimic disease recurrence or progression. In one documented case, withdrawal symptoms were initially mistaken for signs that a patient’s paraganglioma had returned. Shaking, sweating, and elevated blood pressure looked enough like a catecholamine-secreting tumor flare that clinicians investigated the wrong direction before recognizing the medication change as the real trigger. Tapering opioids slowly and watching carefully for withdrawal symptoms prevents most of these episodes, but in practice, medication changes in cancer patients often happen in the context of hospitalizations, procedure prep, or transitions between care settings where communication gaps are common.
Radiation-Related Nerve and Muscle Damage
Radiation therapy saves lives, but it can also damage the nerves and muscles in the areas it treats. Over time, radiation-induced fibrosis can develop in soft tissues, and when it affects nerves, the result is a condition sometimes described as radiation fibrosis syndrome. Damage can involve the spinal cord, nerve roots, nerve plexuses, or peripheral nerves, and the resulting muscle weakness, dysfunction, and neuromuscular injury can produce tremors, twitching, or difficulty controlling movements in the affected area.11PubMed Central. Opportunities for rehabilitation of patients with radiation fibrosis syndrome Unlike most other causes of shaking discussed here, radiation-related nerve damage tends to show up months to years after treatment, making it easy to overlook the connection. A patient who finished radiation to the neck years ago might not associate a new arm tremor with that distant treatment, and their current doctor might not either without a thorough history.
Cytokine Activity and Temperature Dysregulation
Beyond the acute rigors of infection or drug infusion, some cancer patients experience ongoing, less dramatic episodes of shaking or shivering tied to disordered temperature regulation. This is particularly well documented after breast cancer, where patients report feeling excessively hot or cold in ways that go beyond typical menopausal hot flashes. Researchers have proposed that this thermal discomfort may stem from excessive pro-inflammatory cytokine activity, the same underlying mechanism that drives fever-related shaking. The similarity between some cancer-associated thermal symptoms and fever has led to the hypothesis that common changes in cytokine signaling may underlie both.12PubMed Central. Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Hormonal therapies used in breast cancer treatment, such as aromatase inhibitors and tamoxifen, add another layer by disrupting the estrogen-mediated thermoregulation that keeps body temperature steady. The result is that some patients live with chronic, low-grade shivering or chills that may not point to any single emergency but are real, disruptive, and rooted in the biology of their disease and its treatment.
Telling One Cause From Another
With so many possible explanations, how do clinicians figure out what is actually causing a cancer patient to shake? Context does most of the work. Timing is the first clue: shaking that starts within hours of a drug infusion points toward a treatment reaction, while a tremor that builds over weeks or months is more suggestive of a brain lesion, nerve damage, or paraneoplastic process. The pattern of shaking matters too. Rigors are unmistakable, involving coarse, whole-body shaking that the patient cannot suppress. A resting tremor that is worse in one hand and improves during intentional movement suggests basal ganglia involvement. Sudden muscle jerks (myoclonus) that worsen with attempted movement point toward paraneoplastic or metabolic causes.
Lab work catches many metabolic explanations quickly. Calcium, magnesium, potassium, blood sugar, kidney function, and infection markers are typically checked early. A medication review can identify dopamine-blocking drugs or recent opioid changes. Brain imaging is reserved for cases where the pattern suggests a central nervous system problem, and antibody testing for paraneoplastic syndromes is pursued when the clinical picture is otherwise unexplained and evolving rapidly. The challenge is that cancer patients often have several contributing factors at once: they might be mildly hypocalcemic, on a dopamine-blocking antiemetic, and fighting a low-grade infection simultaneously. Sorting out which factor is dominant, or whether they are all contributing, is part of what makes oncology care complex.
What Families and Caregivers Should Watch For
For people caring for someone with cancer, knowing when shaking warrants an urgent call versus a mention at the next appointment can reduce both unnecessary panic and dangerous delays. Shaking accompanied by fever, confusion, rapid heart rate, or low blood pressure should be treated as an emergency, particularly in patients who are on chemotherapy or known to have low white blood cell counts. New shaking that starts during or shortly after a drug infusion is expected in some treatment protocols, but nursing staff should always be made aware so they can intervene if needed.
A tremor that appears gradually and worsens over days to weeks, especially if it is one-sided, deserves medical attention but is not typically an emergency. The same applies to muscle twitching or stiffness that develops after a medication change. Keeping a simple log of when shaking episodes happen, how long they last, and what else is going on (recent medications, meals, temperature) gives the medical team far more to work with than a general report of “shaking.” Many of these causes are treatable or at least manageable once identified, and the information needed to identify them is often in the details that only the patient or caregiver notices at home.